News
Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...
Cuban, a prominent Kamala Harris supporter in 2024, is praising the president's executive order to lower prescription drug costs.
Some justices may be skeptical of a bid by GSK, Pfizer and others to overturn ruling allowing lawsuits to proceed over claims ...
The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming weight loss and diabetes market.
US tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...
What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its ...
Ohio Attorney General Dave Yost on Monday joined the vast majority of state attorneys general in demanding that Congress make ...
U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...
President Donald Trump’s promise to impose tariffs on pharmaceutical imports is raising red flags among generic drugmakers ...
Bangladeshi pharmaceutical companies are closely monitoring developments following the Trump administration's move to explore imposing tariffs on pharmaceutical imports, a decision that could reshape ...
U.S. President Donald Trump directed his health department on Tuesday to work with Congress on revamping a law that allows ...
Arlington-based Texas Health Resources is suing six drugmakers and pharmacy benefit managers, alleging the parties colluded to drive up the price of insulin, according to court documents obtained by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results